Contact Us - Prohost Biotechnology :: News, Stocks, FDA Approvals, Clinical Trials

My Account
Contact Us

Menu

Home
News & Comments
Today’s Highlights
Prohost Letters
The Week in Review
Subscribe Here
Log in

Home / Contact Us

Name*

Email*

URL

Message*

Thank You! Your message has been sent.

Search ProhostBiotech:

Search for:

Advertisement

Most Recent Articles

Sarepta Announced Successful Results from a Preliminary Trial for Duchenne Muscular Dystrophy
June 19, 2018
Why FDA Approval of Agilent Technologies’ Assay is Important to Cervical Cancer Patients
June 15, 2018
The FDA Approves Keytruda for Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
June 14, 2018
CRISPR Editing and the Two Published Studies
June 12, 2018
More Promising News for Array from Its Melanoma Combination Clinical Trial
June 5, 2018

Hot Tags

AbbVie Inc (ABBV) Agenus (AGEN) Alnylam (ALNY) Amgen (AMGN) Ariad Pharmaceuticals (ARIA) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Biogen Idec (BIIB) Bristol-Myers Squibb (BMY) CAR-T Celgene (CELG) Celldex Therapeutics (CLDX) CompuGen (CGEN) CRISPR Therapeutics (CRSP) Exelixis (EXEL) Gilead Sciences (GILD) GlaxoSmithKline (GSK) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Ionis Pharmaceuticals (ISIS) Jazz Pharmaceuticals (JAZZ) Juno Therapeutics (JUNO) Kite Pharma (KITE) Merck (MRK) Nektar Therapeutics (NKTR) Novartis (NVS) Onyx (ONXX) Pfizer (PFE) Pharmacyclics (PCYC) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron (REGN) Regulus Pharmaceuticals (RGLS) Roche (RHHBY) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seattle Genetics (SGEN) Sequenom (SQNM) Theravance Biopharma (TBPH) Theravance Inc (THRX) Vertex (VRTX) Xoma (XOMA)

© 2014 Prohost Biotech. All rights reserved.

In-depth Analysis and Reports on Biotech Industry

Privacy Policy
Cancellation Policy
Forward Looking Statement